Singapore's TauRx mulls Nasdaq IPO and sees a future for Alzheimer's treatment
Jan 07 - 2016 04:03 AM
Singapore-based TauRx is expected to complete global Phase III trials this year for its Alzheimer's candidate, tau aggregation inhibitor LMTX, that will either start a new chapter in treatment or join a long list of flops.
Scots dementia drug could delay disease by 15 years
May 05 - 2015 03:00 PM
A DRUG said to halt the onset of Alzheimer’s disease could be on the market in two years after a promising performance in clinical trials.
Aberdeen scientists developing Alzheimer's drug that could transform the lives of sufferers
May 03 - 2015 03:05 PM
A drug being developed in Aberdeen could transform the lives of millions of Alzheimer’s sufferers.
Treatment to target tangles
Mar 01 - 2015 02:58 PM
SINGAPORE—Tangles of neuronal fibers are correlated with abnormalities in brain scans of patients with Alzheimer’s disease (AD), but nobody has an approved treatment to target the tangles at the moment, according to Dr. Claude Wischik, co-founder of TauRx Therapeutics Ltd.
Could the solution to treating Alzheimer's Disease really be this simple?
Feb 15 - 2015 03:09 PM
Drug developers have struggled mightily in their attempts to slow Alzheimer's progression, but researchers may have discovered a simple pathway that could lead to new life-improving Alzheimer's drugs.